Cargando…
Inhibition of SIRT6 potentiates the anti-tumor effect of doxorubicin through suppression of the DNA damage repair pathway in osteosarcoma
BACKGROUND: SIRT6 has diverse roles in cells, and the role of SIRT6 in tumorigenesis is controversial. Considering the role of SIRT6 as an inducer of DNA damage repair, it might be involved in resistance to anti-cancer therapy. METHODS: We evaluated the prognostic significance of SIRT6 in 37 osteosa...
Autores principales: | Zhang, Zhongkai, Ha, Sang Hoon, Moon, Young Jae, Hussein, Usama Khamis, Song, Yiping, Kim, Kyoung Min, Park, See-Hyoung, Park, Ho Sung, Park, Byung-Hyun, Ahn, Ae-Ri, Lee, Sang-A, Ahn, Su Jin, Kim, Jung Ryul, Jang, Kyu Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670730/ https://www.ncbi.nlm.nih.gov/pubmed/33198792 http://dx.doi.org/10.1186/s13046-020-01759-9 |
Ejemplares similares
-
The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma
por: Park, Hye Jeong, et al.
Publicado: (2018) -
CK2α/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway
por: Hussein, Usama Khamis, et al.
Publicado: (2021) -
FAM83H is involved in stabilization of β-catenin and progression of osteosarcomas
por: Kim, Kyoung Min, et al.
Publicado: (2019) -
Expression of IL4Rα and IL13Rα1 are associated with poor prognosis of soft-tissue sarcoma of the extremities, superficial trunk, and retroperitoneum
por: Kim, Kyoung Min, et al.
Publicado: (2021) -
Expression of FAM83H and ZNF16 are associated with shorter survival of patients with gallbladder carcinoma
por: Ahn, Sung Woo, et al.
Publicado: (2020)